Curing Parkinson’s Disease
No one needs to tell you that a Parkinson’s diagnosis is serious. So, any news at all about treating this disease is good news indeed. Now, there is some great news. It has to do with something safe and simple: the amino acid l-dopa.
Parkinson’s disease is caused by a lack of the brain chemical dopamine. l-dopa is what dopamine is made from. Neurologists have long known that if you can just give a Parkinson’s patient enough l-dopa, the symptoms will disappear. But that’s the problem. In most cases, long before you can get to the high doses needed to reverse the symptoms, they cause serious side effects. But what if there was a way to give really high doses of l-dopa without any side effects at all? That’s the good news. There is now a way to do just that; and using this method, it is possible to essentially cure Parkinson’s.
Rod is a 68 year old man who has suffered from Parkinson’s for eight years. Despite all of the best neurological care and medications he was completely disabled. He could not walk without a walker. He could not even take care of the basic necessities of life. Amazingly, after Rod was on the new Parkinson’s protocol for only eight weeks, he was completely free of symptoms. Since then, he has resumed a normal life, even to the point of elk hunting. If you saw him you would have no idea there was anything wrong with him at all.
Dr. Hinz made the remarkable discovery that the side effects doctors see with high doses of l-dopa are not caused by l-dopa itself. They are caused by an imbalance in the other brain chemicals. It happens because when you increase the amount of one brain chemical you also affect the levels of the others.
For example, consider the brain chemicals epinephrine, nor-epinephrine and serotonin. All of these brain chemicals are synthesized by the same enzymes that the body uses to convert l-dopa into dopamine. They are also all transported across cell membranes by the same transporters. And lastly, they are all eliminated by the same enzymes. This means that if you do something to increase the level of one of them, it affects the balance of the others.
Here is the important and revolutionary aspect of Dr. Hinz’s work: he has discovered a system that is able to keep the levels of all of the other brain chemicals in balance even when very high levels of l-dopa are used. This allows a complete resolution of symptoms. For example, the highest levels of l-dopa that a doctor can use (due to side effects) are around 6-800 mg per day. However, one patient had to receive 13,000 mg before his symptoms disappeared. If his other brain chemicals were not kept in balance, he could never have taken so much l-dopa. That’s the miracle of Dr. Hinz’s discovery.
By properly supplying the amino acids for serotonin, epinephrine, and nor-epinephrine at the same time that increasing doses of l-dopa are given, we now have a way to give the high levels of l-dopa that are needed to cure Parkinson’s. But everyone is different. And that means that each person with Parkinson’s has a different balance of brain chemicals. Therefore, there is not just one mixture of amino acids that will work for everybody. There has to be a way to find the exact mixture that will work for each individual. Dr. Hinz has also discovered how to do that.
He discovered a highly sophisticated way to analyze the balance of brain chemicals in the laboratory. He gives patients a special mix of l-dopa and other amino acids during their first visit. Then, one week later, a lab test determines how the original mix needs to be altered. This procedure is continued until the exact formula of aminos is discovered for each individual patient.
To learn more about this remarkable treatment, and to see a patient’s story, go to www.youtube.com/thenvcenterantiaging. Just click on “Rod-Parkinson’s Disease.”
1.Fahn S; and the Parkinson Study Group. Does levodopa slow or hasten the rate of progression of Parkinson’s disease? J Neurol. 2005 Oct;252 Suppl 4:IV37-IV42.
2. Hinz M, Stein A, Uncini T. Amino acid management of Parkinson’s disease: a case study International Journal of General Medicine 2011:4 165–174.
3. Hinz M, Stein A, Uncini T. The dual-gate lumen model of renal monoamine transport Neuropsychiatric Disease and Treatment 2010:6 387–392.
4. Trachte GJ, Uncini T, Hinz M.Both stimulatory and inhibitory effects of dietary 5-hydroxytryptophan and tyrosine are found on urinary excretion of serotonin and dopamine in a large human population Neuropsychiatric Disease and Treatment 2009:5 227–235.